Your browser doesn't support javascript.
loading
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019.
Ugurel, Selma; Röhmel, Joachim; Ascierto, Paolo A; Becker, Jürgen C; Flaherty, Keith T; Grob, Jean J; Hauschild, Axel; Larkin, James; Livingstone, Elisabeth; Long, Georgina V; Lorigan, Paul; McArthur, Grant A; Ribas, Antoni; Robert, Caroline; Zimmer, Lisa; Schadendorf, Dirk; Garbe, Claus.
Afiliação
  • Ugurel S; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen & German Cancer Consortium Heidelberg, Germany. Electronic address: selma.ugurel@uk-essen.de.
  • Röhmel J; Bremen, Germany.
  • Ascierto PA; Melanoma, Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy.
  • Becker JC; Translational Skin Cancer Research, German Consortium of Translational Cancer Research (DKTK), Essen, & German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Grob JJ; Department of Dermatology, Timone Hospital and Aix-Marseille University, Marseille, France.
  • Hauschild A; Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany.
  • Larkin J; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Livingstone E; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen & German Cancer Consortium Heidelberg, Germany.
  • Long GV; Melanoma Institute Australia, The University of Sydney, And Royal North Shore Hospital, Sydney, NSW, Australia.
  • Lorigan P; University of Manchester / the Christie NHS Foundation Trust, Manchester, UK.
  • McArthur GA; Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia and University of Melbourne, Parkville, VIC, Australia.
  • Ribas A; University of California, Los Angeles, CA, USA.
  • Robert C; Gustave Roussy Cancer Campus, Villejuif Grand-Paris, France.
  • Zimmer L; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen & German Cancer Consortium Heidelberg, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen & German Cancer Consortium Heidelberg, Germany.
  • Garbe C; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
Eur J Cancer ; 130: 126-138, 2020 05.
Article em En | MEDLINE | ID: mdl-32179447
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Inibidores de Proteínas Quinases / Melanoma Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Inibidores de Proteínas Quinases / Melanoma Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Eur J Cancer Ano de publicação: 2020 Tipo de documento: Article